Legend Biotech (LEGN) Intangibles (2019 - 2025)

Legend Biotech has reported Intangibles for 7 years, with the latest figure at $2.1 million in Q2 2025.

• For the quarter ending Q2 2025, Intangibles fell 22.91% year-over-year to $2.1 million; the trailing twelve-month figure through Jun 2025 stood at $2.1 million (down 22.91% YoY), and the FY2024 full-year result was $2.2 million, down 46.81% from the prior year.
• Intangibles for Q2 2025 stood at $2.1 million, up from $2.1 million in the prior quarter.
• The five-year high for Intangibles was $5.4 million in Q3 2021, with the low at -$1.7 million in Q4 2021.
• Historically, Intangibles has averaged $2.7 million across 5 years, with a median of $2.6 million in 2024.
• The largest YoY upside for Intangibles was 521205.18% in 2021 against a maximum downside of 414.37% in 2021.
• Legend Biotech's Intangibles stood at -$1.7 million in 2021, then soared by 298.43% to $3.4 million in 2022, then advanced by 19.13% to $4.1 million in 2023, then plunged by 46.81% to $2.2 million in 2024, then retreated by 1.06% to $2.1 million in 2025.
• The last three Intangibles figures came in at $2.1 million (Q2 2025), $2.1 million (Q1 2025), and $2.2 million (Q4 2024), per Business Quant data.